| Dr Douglas A Huff | |
|
210 N Chestnut St, Barnesville, OH 43713-1248 | |
| (740) 425-2605 | |
| (740) 425-3158 |
| Full Name | Dr Douglas A Huff |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 210 N Chestnut St, Barnesville, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588835052 | NPI | - | NPPES |
| 277-42-2919-001 | Other | MEDICAL MUTUAL | |
| 0400600001 | Other | ADMINISTAR | |
| 000000118497 | Other | ANTHEM | |
| 0487549 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Douglas A Huff 210 N Chestnut St, Po Box 459, Barnesville, OH 43713-1248 Ph: (740) 425-2605 | Dr Douglas A Huff 210 N Chestnut St, Barnesville, OH 43713-1248 Ph: (740) 425-2605 |
News Archive
Leica Microsystems announce the launch of its clinical workflow solution for Digital Pathology at Pathology Visions 2011. Digital Image Hub Enterprise* with its powerful image management, integration and communication capabilities, in conjunction with a new high performance, intuitive client viewer, SlidePath Gateway*, combine to make this the ideal solution for clinical centers moving towards true Digital Pathology implementation. Furthermore, Leica's Total Digital Pathology solutions now provide an implementation of the DICOM Supplement 145 standard for both slide scanning and viewing.
Boehringer Ingelheim today announced overall survival (OS) results from the LUX-Lung 8 trial (NCT01523587) that directly compared the efficacy and safety of two EGFR-directed treatments, afatinib and erlotinib, in patients with advanced squamous cell carcinoma (SCC) of the lung, progressing after treatment with first-line chemotherapy. Treatment with afatinib significantly reduced the risk of death by 19%, extending the survival of patients to a median of 7.9 months compared to 6.8 months on erlotinib.
August is National Hair Loss Awareness Month and it's an important time for men and women to talk to their doctors about the newest tests and treatments available to help them. Over 100 million Americans are affected - including 60 million men and 40 million women.
Researchers of the hereditary cancer research group at the Bellvitge Biomedical Research Institute and the Catalan Institute of Oncology conducted a functional and structural study of seven missense variants of the BRCA1 gene concluding that three of these variants are pathogenic, linked to the risk of suffering breast or ovarian cancer.
"Former Presidents George W. Bush and Bill Clinton clasped hands with residents of one of Haiti's massive tent cities Monday" during a tour of Port-Au-Prince, the Associated Press reports.
› Verified 7 days ago
Melissa Susan Leach, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 177 E Main St, Barnesville, OH 43713 Phone: 740-425-7000 | |
Barnesville Vision Center, Llc Optometrist Medicare: Medicare Enrolled Practice Location: 177 E Main St, Barnesville, OH 43713 Phone: 740-425-7000 | |
Douglas Alan Huff, O. D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 210 North Chestnut Street, Barnesville, OH 43713 Phone: 740-425-2605 Fax: 740-425-3158 | |
Zachary A. Leach, O.d. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 177 E Main St, Barnesville, OH 43713 Phone: 740-425-7000 Fax: 740-425-7001 | |
Barnesville Vision Center Optometrist Medicare: Not Enrolled in Medicare Practice Location: 177 E Main St, Barnesville, OH 43713 Phone: 740-425-7000 |